Advancing Research for potential respiratory syncytial virus (RSV) Treatment
Unvaccinated & Vaccinated are Welcome!!!
*Participation is confidential, no insurance or social security information will be collected
*Participation is confidential, no insurance or social security information will be collected
For over 35 years, Gilead has been focused on researching antiviral treatments that can make a difference in the lives of patients. We're always testing new medicines to make sure that they're safe and effective for people of all ages. Our goal is to find treatments for RSV to give patients and their families hope and confidence when it comes to treatment.
"We have never been in a better position to end the pandemic".
Clearview Medical Research, LLC is working with Gilead Sciences Inc. to investigate if several newly developed investigational treatments (in different phases) will be effective at treating RSV Infection. A variety of options is available to address your symptoms, the severity of your condition, and your risk factors. However, there are no FDA approved treatments for RSV at this time. Study staff if available from 8am-9pm to address your concerns immediately and get your scheduled for your first visit. Below please find some general information about clinical trials for COVID-19
"We have never been in a better position to end the pandemic".
Clearview Medical Research, LLC is working with Gilead Sciences Inc. to investigate if several newly developed investigational treatments (in different phases) will be effective at treating RSV Infection. A variety of options is available to address your symptoms, the severity of your condition, and your risk factors. However, there are no FDA approved treatments for RSV at this time. Study staff if available from 8am-9pm to address your concerns immediately and get your scheduled for your first visit. Below please find some general information about clinical trials for COVID-19
General Criteria
To qualify:
Qualified Patients will receive:
- Positive test for RSV Infection (not older than 3 days)
- Have not received treatment for RSV in the past 30 days
- Currently experiencing RSV symptoms.
- Other Criteria apply
Qualified Patients will receive:
- No-cost Study related treatment from the study doctor
- No-cost study drug
- Reimbursement for time and travel ($100 dollars at each visit)
- Other study specific benefits